Neurostimulation Devices Market (By Technology: Aneurysm coiling & embolization devices, Cerebral balloon angioplasty & Stenting systems, Support devices, Neurothrombectomy devices; By Disease Pathology: Ischemic Strokes, Cerebral Aneuryms, Carotid Artery Stenosis, Arteriovenous Malformations and Fistulas, Other Diseases; By Product; By Application; By End Users) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2022-2030

The global neurostimulation devices market size was esteemed at USD 8.93 billion in 2021 and is projected to surpass around USD 23.9 billion by 2030, enrolling growth at a CAGR of 11.57% from 2022 to 2030.

Neurostimulation Devices Market Size 2022 to 2030

Key Takeaways:

  • North America neurostimulation devices market size was reached at USD 7.2 billion in 2021.
  • North America garnered market share of around 61% in 2021 and it is expected to grow at a CAGR of 10.4% from 2022 to 2030.
  • By product, the germany neurostimulation devices market was valued at USD 148 million in 2021 with a CAGR of 14% over timeframe.
  • The spinal cord trigger product segment contributed 56% revenue share in 20201. 
  • Based on product, the deep brain stimulator (DBS) segment is expected to grow at a CAGR of 12.8% from 2022 to 2030.
  • The pain management application segment drove the market in 2021 and represented the greatest income portion of over 69%.

Growth Factors

Neurostimulation is a cycle that utilizes an implantable clinical gadget to balance and modify brain exercises for restorative purposes. Hardware utilized for neuromodulation are called neurostimulators and the cycle is named neurostimulation.

A portion of the key factors driving the market incorporate the developing geriatric populace, the presentation of mechanically progressed items, heightening item interest as extra treatment, a rising rate of ongoing illnesses, like headache and epilepsy, and the presence of exceptionally neglected clinical requirements in these sickness sections. Likewise, the rising predominance of neurological problems and way of life related messes, outer subsidizing for R&D, and interest for insignificantly intrusive medical procedures are different elements impelling the market development. As per the American Academy of Neurology, stroke is positioned as the third-driving reason for death in the U.S., with Alzheimer's being positioned as the 6th driving reason for death.

Neurological problems like Alzheimer's illness, Parkinson's infection, epilepsy, and cerebrovascular sicknesses influence the focal sensory system (CNS) and fringe sensory system (PNS) of the human body. To deal with these neurological issues, neurostimulation procedure assumes an essential part. The anodes in the gadgets produce gentle electrical motivations to enhance the neurological exercises in the patients. These gadgets are can be embedded or can be outside. Neurostimulation gadgets are straightforwardly positioned inside the cerebrum, PNS or CNS. Spinal cord triggers, profound cerebrum triggers, sacral nerve triggers, and vagus nerve triggers are a portion of the neurostimulation gadgets utilized in treating patients with different sicknesses like torment the executives, hearing misfortune, urinary incontinence, Parkinson's illness, and epilepsy.

Roughly 48 million individuals are impacted in America and almost 360 million individuals around the world, as per the information distributed by the Hearing Health Foundation in 2020. Moreover, according to the information distributed by the Epilepsy Center, by and by, around 50 million patients are living with epilepsy overall and around 2.4 million new cases are analyzed yearly. In addition, larger part of the epileptic cases is idiopathic, with no recognizable reason. Likewise, as indicated by the U.S. Habitats for Disease Control and Prevention's National Center for Health Statistics, in 2014, around half of more seasoned Americans experienced urinary or gut spillage; around 25% had moderate to serious urinary spillage, and around 8% had moderate to extreme gut spillage. According to the information distributed by WHO, in 2017, the predominance of urinary incontinence goes from 9.9% to 36.1% (detailed in populace based examinations). These expansion in occurrences and ascend in commonness of neurological problems are supposed to fuel the development of the market.

The factors, for example, ascend in commonness of way of life illnesses like sorrow and ongoing torment, expansion in number of neurological problems, and speculation for neurological R&D drive the development of the worldwide neurostimulation gadgets market. In addition, ascend sought after for negligible obtrusive medical procedure, reception of mechanically progressed items, and flood in maturing populace likewise move the development of the market as they are more powerless to neurological issues, like Epilepsy, Parkinson's sickness, Alzheimer's illness, and persistent agony. Notwithstanding, secondary effects, for example, unfavorably susceptible response and shivering or prickling of the skin because of implantation of neurostimulation gadget into the body and expansion in cost of gadgets are supposed to limit the development of the market. Moreover, accessibility of other treatment choices, for example, drug treatments and medical procedures limit the market development. Going against the norm, research in regards to the utilization of neurostimulators for overseeing sicknesses like fanatical urgent problems, interstitial cystitis, and asthma are continuous and are supposed to set out rewarding open doors for the development of the neurostimulation gadgets market before very long.

Insights from a similar source demonstrate that Parkinson's influences almost 1 million Americans with no less than 60,000 new cases that are accounted for yearly. In this manner, with the rising instances of neurological sicknesses, the interest for neurostimulation gadgets is supposed to not long from now develop. In addition, makers are putting more in R&D for the improvement of cutting edge items and advances, for example, implantable neurostimulation gadgets, as most would consider being normal to support the market development. Neurostimulation gadget implantation is a negligibly intrusive interaction and the rising interest for such medical procedures, because of more limited emergency clinic stays and quicker recuperation, is supposed to offer new learning experiences for the market.

Report Scope of the Hormone Replacement Therapy Market

Report Coverage Details
Market Size by 2030 USD 23.9 Billion
Growth Rate from 2022 to 2030

CAGR of 11.57%

North America Market Share in 2021 61%
Spinal Cord Trigger Product Segment Market Share in 2021 56%
Base Year 2021
Forecast Period 2022 to 2030
Segments Covered Technology, Disease Pathology, Product, Application, End Users, Geography
Companies Mentioned Medtronic PLC, Cyberonics, Boston Scientific Corp., St. Jude Medical, Inc., Nevro Corp., MicroPort Scientific Corporation (China), Kaneka Corp. (Japan), Integer Holdings Corporation, BALT (France), Perflow Medical, Phenox GmbH (Germany), Sensome (France)

Technology Insights

The aneurysm snaking and embolization gadgets portion is normal record for the biggest portion of the neurovascular gadgets market during the conjecture time frame. In 2021, attributable to developing end-client inclination for negligibly obtrusive neurosurgical methods and expanding market accessibility of embolic loops for neurovascular treatment.

Disease Pathology Insights

The cerebral aneurysm fragment is assessed to represent the biggest portion of the worldwide interventional nervous system science market during the estimate time frame. The cerebral aneurysm portion is assessed to represent the biggest portion of the worldwide interventional nervous system science market, by pathology, in 2021, drove by the developing reception of negligibly obtrusive neurosurgical methodology among neurosurgeons, expanding medical care use in arising nations, and expanding occurrence of hazard factors, (for example, hypertension, cigarette smoking, elevated cholesterol, diabetes, and stoutness).

Products Insights

The spinal cord trigger segment dominated the market in 2021. Mechanical headways in this section are supposed to drive the portion further. Spinal cord triggers are utilized in non-harmful constant neuropathic torment the executives as they assist with concealing the agony by delivering little nerve driving forces without rolling out any physical improvements to the objective region.

Neurostimulation Devices Market Share, By Product, 2021 (%)

Deep cerebrum triggers are utilized in the treatment of a few neurological issues, particularly Parkinson's illness. These gadgets depend on a beginning innovation and hence are presently going through an exploratory stage. The utilization of these gadgets for infections, like Alzheimer's, Tourette condition, headstrong epilepsy, group cerebral pain, trigeminal neuralgia, and development problems by different sclerosis, is anticipating FDA endorsement. Sacral nerve triggers, utilized in the therapy of ongoing sicknesses including urinary incontinence and waste incontinence, are supposed to witness the quickest CAGR from 2022 to 2030. Expanding mindfulness in regards to these gadgets is supposed to be the significant driving variable for this portion. In any case, different dangers related with the implantation of these gadgets, for example, mechanical disappointments and post-medical procedure torments and diseases, may thwart the section development somewhat.

Application Insights

The pain management segment accounted largest market share in 2021. The high predominance of constant torment issues and developing item use for torment the board by virtue of its high restorative worth are the key elements driving the development of this fragment. The portion is supposed to enlist the quickest CAGR also over the estimate period. A portion of the infections enveloped under this fragment incorporate ongoing torment, plate a medical procedure torment, and leg torment.

Epilepsy is a seizure-causing neurological confusion and influences roughly 50 million individuals across the globe, as indicated by the World Health Organization (WHO). The high item viability showed in treating epilepsy combined with the accessibility of restricted treatment choices for the illness is supposed to prompt the fragment development during the forecast period. Fundamental quakes are portrayed by extreme compulsory appendage development. The infection likewise influences the neck, jaw, and other body parts. The developing geriatric populace across the globe is one of the greatest effect delivering drivers for the development of this portion. The rising instances of melancholy are likewise prone to add to the market improvement as neurostimulation hardware gives simple treatment by initiating or hindering electrical brain signals.

End User Insights

In light of end-client, the neurovascular gadgets market has been sectioned into emergency clinics and careful focuses, mobile consideration places, and examination labs, and scholastic establishments. Starting around 2020, emergency clinics and careful focuses are assessed to represent the biggest portion of the worldwide market in 2021, while wandering consideration places are projected to enroll the most noteworthy CAGR during the forecast period. Developing patient inclination for negligibly obtrusive operations, rising number of wandering a medical procedure community across created nations, alongside the simplicity of planning, the engaged clinical staff, the better efficiency, and the expanded security, and viability of these focuses, are the main considerations that are supposed to drive the development of this end-client fragment before long.

Regional Insights

North America is supposed to be the biggest market during the conjecture time frame. The neurovascular gadgets market in North America is driven principally by elements, for example, the critical illness trouble, expanded number of negligibly obtrusive nervous system science strategies, and proceeded with extension of injury/crisis care offices in US. The severe unofficial laws and an ascent in the normal number of days expected in the FDA endorsement cycle might hamper the district's development. Europe followed North America, as far as income share. Quick financial improvement in Eastern European nations is supposed to speed up this development further. Besides, since getting a CE endorsement is simpler than getting an FDA endorsement, the creation entrance is moderately higher around here.

Neurostimulation Devices Market Share, By Region, 2021 (%)

In addition, the developing geriatric populace in the locale is probably going to help the market development. Then again, Asia Pacific is supposed to be the quickest developing local market from 2022 to 2030. This development can be ascribed to the way that few global makers are moving their creation bases around here because of the presence of neglected clinical requirements and undiscovered learning experiences. Moreover, the fast financial advancement in arising nations, like India and China, and rising medical care consumptions are assessed to help the market improvement in the APAC locale.

Key Players Insights

The key market players are constantly engaged in various developmental strategies like partnership, collaborations, new product launches, and acquisitions to strengthen their market position and gain market share.

Some of the prominent players

  • Medtronic PLC
  • Cyberonics
  • Boston Scientific Corp.
  • St. Jude Medical, Inc.
  • Nevro Corp.
  • MicroPort Scientific Corporation (China), 
  • Kaneka Corp. (Japan)
  • Integer Holdings Corporation
  • BALT (France)
  • Perflow Medical
  • Phenox GmbH (Germany)
  • Sensome (France)

Segments Covered in the Report

(Note*: We offer report based on sub segments as well. Kindly, let us know if you are interested)

By Technology

  • Aneurysm coiling & embolization devices
    • Embolic coils
      • Bare detachable coils
      • Coated detachable coils
    • Flow diversion devices
    • Liquid embolic agents
  • Cerebral balloon angioplasty & Stenting systems
    • Carotid artery stents
    • Embolic protection devices
    • Balloon catheters
  • Support devices
    • Microcatheters
    • Guidewires
  • Neurothrombectomy devices
    • Clot retrievals
    • Suction & aspiration devices
    • Snares

By Disease Pathology

  • Ischemic Strokes
  • Cerebral Aneuryms
  • Carotid Artery Stenosis
  • Arteriovenous Malformations and Fistulas
  • Other Diseases

By Product

  • Spinal Cord Stimulator
  • Deep Brain Stimulator
  • Sacral Nerve Stimulator
  • Vagus Nerve Stimulator
  • Gastric Electric Stimulator

By Application

  • Pain Management
  • Epilepsy
  • Essential Tremor
  • Urinary and Fecal Incontinence
  • Depression
  • Dystonia
  • Gastroparesis
  • Parkinson’s Disease
  • Others

By End Users

  • Hospitals & Surgical Centers
  • Ambulatory Care Centers
  • Research Laboratories & Academic Institutes

By Geography

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • France
  • Asia-Pacific
    • China
    • India
    • Japan
    • South Korea
    • Malaysia
    • Philippines
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC
    • North Africa
    • South Africa
    • Rest of the Middle East & Africa

Frequently Asked Questions

What is the current size of neurostimulation devices market?
The global neurostimulation devices market size was accounted at USD 8.93 billion in 2021 and it is expected to reach around USD 23.9 billion by 2030.
The global neurostimulation devices market is poised to grow at a CAGR of 11.57% from 2022 to 2030.
The major players operating in the neurostimulation devices market are Medtronic PLC, Cyberonics, Boston Scientific Corp., St. Jude Medical, Inc., Nevro Corp., MicroPort Scientific Corporation (China), Kaneka Corp. (Japan), Integer Holdings Corporation, BALT (France), Perflow Medical, Phenox GmbH (Germany), Sensome (France)
The key factors driving the market incorporate the developing geriatric populace, the presentation of mechanically progressed items, heightening item interest as extra treatment, a rising rate of ongoing illnesses, like headache and epilepsy, and the presence of exceptionally neglected clinical requirements in these sickness sections.
North America region will lead the global neurostimulation devices market during the forecast period 2022 to 2030.
  • Report Code:1853
  • Category:Healthcare
  • No. of Pages:150+
  • Format:PDF/PPT/Excel
  • Status:Published


   USD 4500
   USD 7000
   USD 9000


No cookie-cutter, only authentic analysis – take the 1st step to become an Precedence Research client

Get a Sample